<div class="container">

<table style="width: 100%;"><tr>
<td>E1684</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>ECOG E1684 Trial</h2>

<h3>Description</h3>

<p>A data set from the ECOG E1684 trial comparing the high-dose interferon alfa-2b (IFN)
therapy with the observation in resected high-risk melanoma patients. The study results
were described in Kirkwood et al. (1996) <a href="doi:10.1200/JCO.1996.14.1.7">doi:10.1200/JCO.1996.14.1.7</a>.
</p>


<h3>Usage</h3>

<pre><code class="language-R">E1684
</code></pre>


<h3>Format</h3>

<p>A data frame with 262 rows and 8 variables:
</p>

<dl>
<dt>failtime</dt>
<dd>
<p>time to relapse in years</p>
</dd>
<dt>failcens</dt>
<dd>
<p>censoring indicator for time to relapse, 0 = did not relapse, 1 = relapsed</p>
</dd>
<dt>survtime</dt>
<dd>
<p>time to death in years</p>
</dd>
<dt>survcens</dt>
<dd>
<p>censoring indicator for time to death, 0 = alive, 1 = dead</p>
</dd>
<dt>treatment</dt>
<dd>
<p>treatment indicator, 0 = observation, 1 = high-dose IFN</p>
</dd>
<dt>sex</dt>
<dd>
<p>gender indicator, 0 = male, 1 = female</p>
</dd>
<dt>age</dt>
<dd>
<p>patient age in years</p>
</dd>
<dt>node_bin</dt>
<dd>
<p>indicator for having more than one cancerous lymph node,
0 = with one or no cancerous lymph nodes,
1 = with more than one cancerous lymph node</p>
</dd>
</dl>
<h3>References</h3>

<p>Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., and Blum, R. H. (1996). Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684. Journal of Clinical Oncology, 14(1), 7â€“17.
</p>


</div>